Pathology Queue Left Sarah Daniels Without Timely Results

Nine-month histology delay recorded at Cwm Taf Morgannwg after ovarian mass removal

Nine months passed between the removal of an ovarian mass from Sarah Catherine Daniels and the delivery of pathology results confirming her cancer. By then the 43-year-old mother of three had already been living with stage-four metastatic signet ring adenocarcinoma of the appendix since October 2021. The inquest at Pontypridd Coroners’ Court recorded that the delay reduced her chance of successful chemotherapy.

The Cwm Taf Morgannwg University Health Board pathology department was overwhelmed by a post-pandemic backlog of routine work that had been suspended during Covid restrictions. Biomedical scientist Martin Ludlam told the court that staffing and capacity proved insufficient to clear both the accumulated samples and new demand. Outsourcing was introduced only later, and the board acknowledged it had still not completed a full system overhaul.

Sarah had opted for the less invasive procedure to avoid early menopause. Samples were sent promptly after surgery in February 2022, yet results arrived nine months later with a terminal prognosis of twelve months. Consultant Mohamed Khalifa stated the Risk of Malignancy Index had been incorrectly reassuring during that interval. Treatment at Velindre Cancer Centre followed, including ten rounds of chemotherapy, but the window for earlier intervention had closed.

Initial GP referral and MRI scan occurred within acceptable timeframes. The coroner found no fault in those steps or in the decision not to widen imaging when cancer suspicion remained low. The failure sat entirely in the pathology queue, where demand exceeded verified capacity for an extended period.

This pattern of diagnostic delay now repeats across multiple health boards. Backlogs that formed during service suspensions have not been eliminated despite repeated targets. Patients continue to receive results after the point at which earlier treatment could have altered disease trajectory or extended survival.

The Daniels case shows how capacity shortfalls in one department translate directly into lost months of life. No structural adjustment has yet restored pre-pandemic throughput in cellular pathology for this board. Similar shortfalls persist in other regions, leaving the same gap between referral speed and diagnostic completion.